The Effect of Rebamipide for Non-steroidal Anti-inflammatory Drugs (NSAID) - Induced Small-intestinal Injuries

NSAIDs-induced Small-intestinal Injuries Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of rebamipide for NSAID-induced small-intestinal injuries.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• NSAIDs-induced Small-intestinal Injuries

• NCT number: NCT00862628
• Study type: Interventional
• Source: Nagoya University
• Contact: Naoki Ohmiya, MD., Ph.D.
• Phone: 81-52-744-2172
• Email: nohmiya@med.nagoya-u.ac.jp
• Status: Not yet recruiting
• Phase: N/A
• Start date: October 2009
• Completion date: October 2010